We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Neurochemical Behind Visual Stimulation Identified
News

Neurochemical Behind Visual Stimulation Identified

Neurochemical Behind Visual Stimulation Identified
News

Neurochemical Behind Visual Stimulation Identified

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Neurochemical Behind Visual Stimulation Identified"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

“Look at me!” we might say while attempting to engage our children. It turns out there is a neurochemical explanation for why looking at mom or dad actually helps kiddos pay better attention.


In a paper published Dec. 17 in the journal Science Advances, authors from The University of Texas Health Science Center at San Antonio (also referred to as UT Health San Antonio) report that norepinephrine, a fundamental chemical for brain performance, is locally regulated in a brain region called the visual cortex.


“Before our study, research suggested the possibility of local regulation of norepinephrine release, but it had never been directly demonstrated,” said study senior author Martin Paukert, MD, assistant professor of cellular and integrative physiology at UT Health San Antonio. The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, the National Institute of Mental Health (NIMH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) supported this work, which included Shawn R. Gray, PhD, and Liang Ye, MD, from the Paukert lab and collaborator Jing Yong Ye, PhD, from the biomedical engineering department at The University of Texas at San Antonio.


Disease states in which norepinephrine is known to be altered include substance use disorders, Alzheimer’s disease, post-traumatic stress disorder (PTSD) and attention-deficit/hyperactivity disorder (ADHD). In some substance use, Alzheimer’s and ADHD, the release of norepinephrine is reduced, resulting in lower attention. In other substance use and PTSD, the level is too high.


The team’s findings also extend to cells called astrocytes that function as helper cells in the brain and central nervous system.


“When a person makes a movement, such as turning the head to listen to a parent, and that is combined with visual stimulation, then more norepinephrine is released where visual information is processed,” Dr. Paukert said. “Our second finding, also important, is that astrocytes can reliably detect the rate of norepinephrine release.”


They are sensitive to it, in other words. Astrocytes alter their response accordingly, which is expected to change brain performance.


“Understanding norepinephrine release, its local regulation and the astrocyte response may represent a mechanism by which one could enhance sensory-specific attention,” Dr. Paukert said. Research will continue in that direction.


Reference: 


Gray SR, Ye L, Ye JY, Paukert M. Noradrenergic terminal short-term potentiation enables modality-selective integration of sensory input and vigilance state. Science Advances. 7(51):eabk1378. doi:10.1126/sciadv.abk1378

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement